Ovarian Cancer ranks fifth in cancer deaths among women, and the American Cancer Society estimates this year, about 21,410 women will receive an ovarian cancer diagnosis and about 13,770 women will die from the disease.

Part of the reason ovarian cancer is so deadly is there are no clearly defined symptoms to watch out for and no screening tests available, which means it's difficult to detect in the early stages. In fact, only 20 percent of ovarian cancer cases are diagnosed in stage I or II.

The good news is, new scientific breakthroughs and cutting-edge technology mean advancements in diagnosis, treatment and prevention are happening every day. Much of this research is funded by Ovarian Cancer Research Alliance (OCRA).

September is Ovarian Cancer Awareness Month, and in this exclusive Q&A with Giddy, representatives from OCRA discuss the latest research and resources available for ovarian cancer patients and survivors, and why there is reason to hope.

Tell us a bit about Ovarian Cancer Research Alliance.

Ovarian Cancer Research Alliance (OCRA) is the leading organization in the